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Scientific objectives
Endometrial hyperplasia (EH) is significant in gynecolo-
gical morbidity of reproductive age women, has high
risk of malignancy and associated with menstrual irregu-
larities, dysfunctional uterine bleeding and anemia. The
incidence of endometrium adenocarcinoma ranks first
among genital malignancies, in recent years has tended
to increase in many countries, including Ukraine. EH
has tended to increase in many countries, including
Ukraine, in recent years. The response to hormone ther-
apy and prognosis of endometrial hyperplastic processes
in women is largely determined by receptor status,
which depends on the clinical stage and degree of histo-
logical differentiation of EH.
The aim
was to determine the state of endometrial receptor sys-
tems in each case of endometrial hyperplasia using
immunohistochemical methods to perform personalized
treatment strategy.
Materials and methods
We included to the study 119 women aged 25 to 45 years
(the average was 38, 0 ± 2, 3 years) treated in Hospital
“Pheophania”, assessed to: group 1 (n = 41) with endome-
trium glandular-cystic hyperplasia; group 2 -patients with
endometrial polyps (n = 53); and group 3 (n = 21) - with
atypical EH; the control group included 22 women, who
underwent in vitro fertilization due to tubal origin inferti-
lity. All patients underwent extensive general clinical
examination, which included clinical and biochemical
blood tests, blood tests for HIV, RW, HBS-Ag and
HCV-Ag, clinical urine tests, ECG, ultrasound, chest X-
rays, a study of vaginal biotope (microflora). The EH was
diagnosed using transvaginal ultrasound followed by
hysteroresection. The resulting material was subjected
to histological study to determine the receptor of
the endometrium cells applying immunohistochemical
method.
Results
In patients with glandular hyperplasia we registered the
sharp increase of estrogen receptors in the endometrium
(75.6% in epithelial cells and 30.9% in stroma, in control
group 43.3% and 29.6%, respectively). Analysis of the
distribution of receptors for progesterone showed them
a slight increase in the endometrium and in the stroma
(1.3 times). In endometrial polyps group we found sig-
nificant increase of estradiol receptors in stroma (48.2%
vs 29.6% in controls). In patients with atypical endome-
trial hyperplasia the significant increase in the content
of progesterone receptors in endometrial stroma -
81.8%. The proliferative marker Ki-67 was determined
significant increased in 40-50% in the epithelium of the
glands in the absence of changes in the stroma com-
pared with glandular hyperplasia.
Outlook and expert recommendations
Thus, our analysis of the ratio of receptor in tissue and
endometrial stroma in patients of observation allows to
conclude as follows:
• These receptor combination patterns are predictive
criteria for determining the subsequent treatment strategy
as the method of screening for uterine cancer pathology.
• Each individual pathological pattern of the definition
of receptors and their relationship further defines perso-
nalized pathogenic tactics.
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• The sharp variations in the receptor status of the
endometrium can be interpreted as a risk factor for
development of genetic mutations and carcinogenesis.
• It is recommended to create a project to perform a
good evidence study of determining relationships in
endometrial receptor system to complement the diag-
nostic algorithm that will allow to conduct pathogenetic
therapy.
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